Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
about
Prescription patterns of long-acting somatostatin analoguesComparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegalyProgress in the formulation and delivery of somatostatin analogs for acromegaly.Direct palladium-mediated on-resin disulfide formation from Allocam protected peptides.
P2860
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@en
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@nl
type
label
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@en
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@nl
prefLabel
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@en
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@nl
P2093
P2860
P356
P1476
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.
@en
P2093
Alberto M Pereira
Ferdinand Roelfsema
Johannes A Romijn
Nienke R Biermasz
P2860
P304
P356
10.2147/BTT.S3356
P577
2008-09-01T00:00:00Z